Public Company News
Sun Life Appoints Chris Wei to EVP and Chief Client and Innovation Officer
TORONTO, Aug. 4, 2022 /PRNewswire/ -- Kevin Strain, President and CEO of Sun Life, is pleased to announce the appointment ofChris Wei as Executive Vice-President and Chief Client and Innovation Officer (CCIO), reporting to him. Chris brings more than 25 years of global leadership experience in i...
2022-08-04 05:20
4492
Franklin Templeton, Inc. Renews with Empire State Realty Trust for 79k Square Feet at 100 First Stamford Place
STAMFORD, Conn., Aug. 4, 2022 /PRNewswire/ -- Empire State Realty Trust, Inc. (NYSE: ESRT) announced thatFranklin Templeton, a global investment management organization, renewed its lease for 79,059 square feet at 100 First Stamford Place, which represents about 10% of building square footage. L...
2022-08-04 04:30
6110
PENFOLDS LAUNCH TWO INAUGURAL FRENCH WINES
THE PENFOLDS COLLECTION 2022 – ONE COLLECTION, TWO HEMISPHERES ADELAIDE, Australia, Aug. 4, 2022 /PRNewswire/ -- For the first time in Penfolds history, the annual Collection release in August will comprise three country of origin portfolios – Australian, Californian and the inaugural French rel...
2022-08-04 04:00
5846
Ping An Ranks 25th in the Fortune Global 500 List, 1st among mixed-ownership Chinese enterprises
HONG KONG and SHANGHAI, Aug. 3, 2022 /PRNewswire/ -- With sustained performance and growth, Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An " or the "Group", HKEX: 2318; SSE: 601318) ranked 25th on the 2022 Fortune Global 500 list with its revenue recordedUSD199.6 billion in 20...
2022-08-03 21:44
5249
China Literature to Report First Half 2022 Financial Results on August 15, 2022
- Earnings Conference Call to be Held on Monday, August 15, 2022 at 8:00 pm (Hong Kong Time) /8:00 am (U.S. Eastern Time) HONG KONG, Aug. 3, 2022 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", 0772.HK), a leading online literature and intellectual property ("IP") ...
2022-08-03 21:15
4550
Autohome 2022 Q2 Revenues Beats Consensus, Sustains Strong Recovery Momentum, Posts Excellent Profitability
HONG KONG, Aug. 3, 2022 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers in China, today announced its unaudited financial results for the three months and six months ending onJune 30, 2022. The Compa...
2022-08-03 19:39
3736
Airtel awards its first 5G contract in India to Ericsson
* Ericsson has partnered with Airtel for more than 25 years, spanning every mobile generation * 5G deployment to get underway in August 2022 STOCKHOLM, Aug. 3, 2022 /PRNewswire/ -- Bharti Airtel (Airtel),India's premier communications solutions provider, today announced that it has awarded it...
2022-08-03 18:52
2852
MARRIOTT INTERNATIONAL SIGNS MEMORANDUM OF UNDERSTANDING (MOU) WITH THE MINISTRY OF TOURISM AND CREATIVE ECONOMY OF THE REPUBLIC OF INDONESIA
The landmark signing is part of a continued effort to develop the tourism sector and the creative economy in the country DENPASAR, Indonesia, Aug. 3, 2022 /PRNewswire/ -- Marriott International Inc. inIndonesia signed a memorandum of understanding (MoU) with The Ministry of Tourism and Creative ...
2022-08-03 18:00
4721
Hisense Shines in UEFA Women's EURO 2022™, Achieved Champion Position in Global Market
QINGDAO, China, Aug. 3, 2022 /PRNewswire/ -- As one of the most awaited games of 2022, UEFA Women's EURO 2022™ ended with England crowned, witnessed by a record 87192 attendance. As a proud partner of the tournament, through years of sports marketing and technological innovation, Hisense has achi...
2022-08-03 17:32
3990
Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients
-- ASC10 is an oral double prodrug that is rapidly and completely converted in vivo into the active metabolite ASC10-A, which is the same active metabolite of molnupiravir -- Ascletis has filed multiple patent applications for ASC10 and its use globally. Compared with molnupiravir, ASC10 has a n...
2022-08-03 16:50
3842
Technology Solutions to Boost Employee Experience and Improve Patient Outcomes
Workforce management solutions from DXC and SAP support healthcare providers in managing their teams while focusing on employees' well-being and ability to deliver quality care SAN ANTONIO, Aug. 3, 2022 /PRNewswire/ -- Healthcare providers may find that supporting their care team and managing th...
2022-08-03 15:12
2884
Yidu Tech Releases FY2022 ESG Report, Using Socially Beneficial Technology to Drive the Sustainable Development of "Green Healthcare"
HONG KONG, Aug. 3, 2022 /PRNewswire/ -- The digital economy powered by innovative technologies such as artificial intelligence ("AI") and big data has become one of the most powerful drivers of economic growth since the COVID-19 outbreak, in keeping withChina's core strategy of "digitalization, ...
2022-08-03 15:09
3394
Integral Ad Science Names Thomas V. Joseph as Chief Technology Officer
Former SiriusXM and Pandora executive will lead the technology organization,
ensuring continued digital media quality leadership and innovation
SINGAPORE, SYDNEY, and MUMBAI, India, Aug. 3, 2022 /PRNewswire/ -- Integral
Ad Science
2022-08-03 13:42
3721
Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines
TAIZHOU, China, Aug. 3, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Company", together with its subsidiaries, the "Group",Stock code:02179.HK) is pleased to announce that, the Company has recently received the clinical trial approval for its recombinant protein COVID-19 vaccine,...
2022-08-03 13:09
5102
Visa launching eco-friendly payment solutions in Asia Pacific
* New Visa Eco Benefits help cardholders understand the environmental impact of their payment transactions * Over half of consumers in Asia Pacific would switch banks for products that help them calculate their carbon footprint SINGAPORE, Aug. 3, 2022 /PRNewswire/ -- Visa, a world leader in d...
2022-08-03 09:30
6972
Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma
* ATG-101 is a novel PD-L1/4-1BB bispecific antibody. It is Antengene's first in-house developed molecule with global rights. * ATG-101 demonstrates potent in vivo efficacy in anti-PD-1/PD-L1 resistant mouse tumor models. SHANGHAI and HONG KONG, Aug. 3, 2022 /PRNewswire/ -- Antengene Corpora...
2022-08-03 08:30
3094
SK hynix Develops World's Highest 238-Layer 4D NAND Flash
* World's first 238-layer 512Gb TLC 4D NAND developed in July; expected to begin mass production in the first half of 2023 * Providing highest, smallest NAND product while remarkably improving productivity, data transfer speed and power efficiency * "Will continue innovations to find breakth...
2022-08-03 05:30
4663
CLA Nearly Triples Office Space with ESRT at One Grand Central Place
NEW YORK, Aug. 3, 2022 /PRNewswire/ -- Empire State Realty Trust, Inc. (NYSE: ESRT) announced today thatCLA (CliftonLarsonAllen LLP), the eighth largest accounting firm inthe United States, expanded to lease the entire 51st floor of One Grand Central Place for a total of 12,422 square feet. CLA i...
2022-08-03 04:30
5481
CELEBRATING CULTURAL REVIVAL AND THE TRADITION OF PASSING ON GENERATIONAL KNOWLEDGE THROUGH A NEW ROYAL CANADIAN MINT COIN HONOURING THE RED RIVER MÉTIS
WINNIPEG, MB, IN THE HEART OF THE NATIONAL HOMELAND OF THE RED RIVER MÉTIS, Aug. 3, 2022 /PRNewswire/ -- The Red River Métis tradition of sharing and preserving knowledge by passing it on from one generation to the next through art and storytelling is celebrated on a new fine silver coin showcasi...
2022-08-03 01:36
5271
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination
Preclinical data support the potential of ONA-XR plus estrogen receptor degraders in endocrine resistant disease models Context to initiate Phase 1b/2 clinical trial in Q4 2022 PHILADELPHIA and FLORENCE, Italy, Aug. 2, 2022 /PRNewswire/ -- Context Therapeutics Inc. ("Context" or the "Company") (...
2022-08-02 22:49
4964
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1169 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1130 media titles]
2026-11-05 06:52Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1118 media titles]
2026-11-06 22:06
Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00NYSE Chair Sharon Bowen Earns Lifetime Achievement Award: NYSE Content Update
[Picked up by 1073 media titles]
2026-11-05 22:05
Most Read
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
63886
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
29052
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
23179
Lorikeet Dreamweaver enables businesses to give every customer an AI account manager
2026-11-04 22:00
19981